Benjamin Marty1,2, Bertrand Coppa3,4, Pierre G Carlier3,4. 1. Institute of Myology, NMR Laboratory, Bâtiment Babinski, Groupe Hospitalier Pitié-Salpêtrière, 47-83 boulevard Vincent Auriol, 75651, Paris Cedex 13, France. b.marty@institut-myologie.org. 2. CEA, DRF, IBFJ, MIRCen, NMR Laboratory, Paris, France. b.marty@institut-myologie.org. 3. Institute of Myology, NMR Laboratory, Bâtiment Babinski, Groupe Hospitalier Pitié-Salpêtrière, 47-83 boulevard Vincent Auriol, 75651, Paris Cedex 13, France. 4. CEA, DRF, IBFJ, MIRCen, NMR Laboratory, Paris, France.
Abstract
OBJECTIVES: To develop a fast, high-resolution T1-mapping sequence dedicated to skeletal muscle imaging, and to evaluate the potential of T1 as a robust and sensitive biomarker for the monitoring of chronic fatty degenerations in a dystrophic disease. METHODS: The magnetic resonance imaging sequence consisted of the acquisition of a 1,000-radial-spokes FLASH echo-train following magnetisation inversion, resulting in 10s scan time per slice. Temporal image series were reconstructed using compressed sensing and T1 maps were computed using Bloch simulations. Ten healthy volunteers and 30 patients suffering from Becker muscular dystrophy (BMD) participated in this prospective study, in order to evaluate the repeatability, the precision and the sensitivity of the proposed approach. Intramuscular fat fraction (FF) was also measured using a standard three-point Dixon method. The protocol was approved by a local ethics committee. RESULTS: The mean T1 evaluated in the thighs muscles of healthy volunteers was 1,199 ± 45 ms, with a coefficient of reproducibility of 2.3%. Mean T1 values were statistically decreased in the thighs of BMD patients and were linearly correlated with intramuscular FF (R = -0.98). CONCLUSIONS: T1-mapping is a good candidate for fast, sensitive and quantitative monitoring of fatty infiltrations in neuromuscular disorders. KEY POINTS: • A T1 mapping sequence dedicated to skeletal muscle imaging was implemented. • The acquisition time was 10 s per slice. • Muscle T1 values were significantly decreased in dystrophic muscles compared to healthy muscles. • T1 values correlated with intramuscular fat fraction measured by three-point Dixon. • T1 represents an alternative biomarker for monitoring fatty infiltrations in neuromuscular disorders.
OBJECTIVES: To develop a fast, high-resolution T1-mapping sequence dedicated to skeletal muscle imaging, and to evaluate the potential of T1 as a robust and sensitive biomarker for the monitoring of chronic fatty degenerations in a dystrophic disease. METHODS: The magnetic resonance imaging sequence consisted of the acquisition of a 1,000-radial-spokes FLASH echo-train following magnetisation inversion, resulting in 10s scan time per slice. Temporal image series were reconstructed using compressed sensing and T1 maps were computed using Bloch simulations. Ten healthy volunteers and 30 patients suffering from Becker muscular dystrophy (BMD) participated in this prospective study, in order to evaluate the repeatability, the precision and the sensitivity of the proposed approach. Intramuscular fat fraction (FF) was also measured using a standard three-point Dixon method. The protocol was approved by a local ethics committee. RESULTS: The mean T1 evaluated in the thighs muscles of healthy volunteers was 1,199 ± 45 ms, with a coefficient of reproducibility of 2.3%. Mean T1 values were statistically decreased in the thighs of BMDpatients and were linearly correlated with intramuscular FF (R = -0.98). CONCLUSIONS: T1-mapping is a good candidate for fast, sensitive and quantitative monitoring of fatty infiltrations in neuromuscular disorders. KEY POINTS: • A T1 mapping sequence dedicated to skeletal muscle imaging was implemented. • The acquisition time was 10 s per slice. • Muscle T1 values were significantly decreased in dystrophic muscles compared to healthy muscles. • T1 values correlated with intramuscular fat fraction measured by three-point Dixon. • T1 represents an alternative biomarker for monitoring fatty infiltrations in neuromuscular disorders.
Authors: Philipp Ehses; Nicole Seiberlich; Dan Ma; Felix A Breuer; Peter M Jakob; Mark A Griswold; Vikas Gulani Journal: Magn Reson Med Date: 2012-02-29 Impact factor: 4.668
Authors: Hee Kyung Kim; Tal Laor; Paul S Horn; Judy M Racadio; Brenda Wong; Bernard J Dardzinski Journal: Radiology Date: 2010-06 Impact factor: 11.105
Authors: Daniel Gensler; Philipp Mörchel; Florian Fidler; Oliver Ritter; Harald H Quick; Mark E Ladd; Wolfgang R Bauer; Georg Ertl; Peter M Jakob; Peter Nordbeck Journal: Radiology Date: 2014-11-13 Impact factor: 11.105
Authors: Nathan D Bryant; Ke Li; Mark D Does; Stephanie Barnes; Daniel F Gochberg; Thomas E Yankeelov; Jane H Park; Bruce M Damon Journal: NMR Biomed Date: 2014-04-29 Impact factor: 4.044
Authors: Dan Ma; Vikas Gulani; Nicole Seiberlich; Kecheng Liu; Jeffrey L Sunshine; Jeffrey L Duerk; Mark A Griswold Journal: Nature Date: 2013-03-14 Impact factor: 49.962
Authors: Sean C Forbes; Rebecca J Willcocks; William T Triplett; William D Rooney; Donovan J Lott; Dah-Jyuu Wang; Jim Pollaro; Claudia R Senesac; Michael J Daniels; Richard S Finkel; Barry S Russman; Barry J Byrne; Erika L Finanger; Gihan I Tennekoon; Glenn A Walter; H Lee Sweeney; Krista Vandenborne Journal: PLoS One Date: 2014-09-09 Impact factor: 3.240
Authors: Lorenzo Maggi; Marco Moscatelli; Rita Frangiamore; Federica Mazzi; Mattia Verri; Alberto De Luca; Maria Barbara Pasanisi; Giovanni Baranello; Irene Tramacere; Luisa Chiapparini; Maria Grazia Bruzzone; Renato Mantegazza; Domenico Aquino Journal: Clin Neuroradiol Date: 2020-01-23 Impact factor: 3.649
Authors: Chia-Ying Liu; Jianhua Yao; William C Kovacs; Joseph A Shrader; Galen Joe; Ronald Ouwerkerk; Ami K Mankodi; William A Gahl; Ronald M Summers; Nuria Carrillo Journal: Neurology Date: 2020-11-20 Impact factor: 9.910
Authors: Kirsten Koolstra; Andrew G Webb; Thom T J Veeger; Hermien E Kan; Peter Koken; Peter Börnert Journal: Magn Reson Med Date: 2020-01-03 Impact factor: 4.668